We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
(+2%)
Cap. Flow
-$91.9M
Cap. Flow
% of AUM
-15.04%
Top 10 Holdings %
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Best Buy
BBY
|
+$2.79M |
| 2 |
Bath & Body Works
BBWI
|
+$2.78M |
| 3 |
Advanced Micro Devices
AMD
|
+$2.7M |
| 4 |
NVIDIA
NVDA
|
+$2.4M |
| 5 |
ExxonMobil
XOM
|
+$2.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$10.9M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$7.99M |
| 3 |
ORPH
Orphazyme A/S
ORPH
|
+$5.06M |
| 4 |
BridgeBio Pharma
BBIO
|
+$3.35M |
| 5 |
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
|
+$3.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.42% |
| 2 | Technology | 16.03% |
| 3 | Healthcare | 14.17% |
| 4 | Industrials | 13.91% |
| 5 | Financials | 11.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
LeMaitre Vascular
LMAT
$1.86B
| $279K | 0.05% |
+6,878
| New | +$246K |
|
777
MSC Industrial Direct
MSM
$6.86B
| $279K | 0.05% |
+3,307
| New | +$255K |
|
778
Pinnacle Financial Partners Inc
PNFP
$15.8B
| $279K | 0.05% |
4,325
-44,019
| -91% | -$2.27M |
|
779
RTX Corp
RTX
$301B
| $279K | 0.05% |
3,900
-903
| -19% | -$59.4K |
|
|
DCPH
780
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $279K | 0.05% |
+4,890
| New | +$290K |
|
781
Frontline
FRO
$8.85B
| $278K | 0.05% |
+44,634
| New | +$287K |
|
782
iShares Expanded Tech-Software Sector ETF
IGV
$14.7B
| $278K | 0.05% |
+3,920
| New | +$260K |
|
|
VNE
783
DELISTED
Veoneer, Inc.
VNE
| $278K | 0.05% |
+13,058
| New | +$247K |
|
784
Ares Capital
ARCC
$14.4B
| $277K | 0.05% |
16,397
+1,138
| +7% | +$17.6K |
|
785
Carvana
CVNA
$77.9B
| $277K | 0.05% |
5,785
-1,660
| -22% | -$75.9K |
|
786
iHeartMedia
IHRT
$583M
| $277K | 0.05% |
+21,333
| New | +$220K |
|
|
EXTN
787
DELISTED
Exterran Corporation
EXTN
| $277K | 0.05% |
62,625
-33,832
| -35% | -$144K |
|
788
ScottsMiracle-Gro
SMG
$3.66B
| $276K | 0.05% |
1,387
-1,030
| -43% | -$177K |
|
789
Bank of America
BAC
$442B
| $275K | 0.05% |
9,072
-2,197
| -19% | -$58.9K |
|
790
Service Corp International
SCI
$11.6B
| $275K | 0.05% |
5,600
-1,280
| -19% | -$60.8K |
|
791
Cognex
CGNX
$11.3B
| $274K | 0.04% |
+3,407
| New | +$248K |
|
792
Cedar Fair
FUN
$1.67B
| $274K | 0.04% |
+6,961
| New | +$231K |
|
793
Royal Bank of Canada
RY
$293B
| $274K | 0.04% |
+3,341
| New | +$259K |
|
794
Barnes & Noble Education
BNED
$443M
| $273K | 0.04% |
588
-595
| -50% | -$197K |
|
795
Popular Inc
BPOP
$11.1B
| $273K | 0.04% |
4,845
-3,315
| -41% | -$157K |
|
796
JPMorgan Chase
JPM
$950B
| $273K | 0.04% |
2,148
-8,206
| -79% | -$917K |
|
797
Phio Pharmaceuticals
PHIO
$12.1M
| $273K | 0.04% |
939
+742
| +377% | +$188K |
|
798
Capricor Therapeutics
CAPR
$237M
| $271K | 0.04% |
+79,091
| New | +$343K |
|
799
Minerva Neurosciences
NERV
$199M
| $271K | 0.04% |
+14,501
| New | +$365K |
|
800
Origin Bancorp
OBK
$1.66B
| $271K | 0.04% |
+9,776
| New | +$249K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.
GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.
- GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
- GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
- GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
- GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
- GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
- GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
- GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.
Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.